Home › Linfoma diffuso a grandi cellule B › Missouri › St. Louis
Studi clinici su Linfoma diffuso a grandi cellule B a St. Louis, MO
8 studi su Linfoma diffuso a grandi cellule B cercano partecipanti presso sedi a St. Louis e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
In reclutamentoFase 2
- Washington University School of Medicine - Siteman Cancer Center, St Louis
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
In reclutamentoFase 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- e altri 2
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
In reclutamentoFase 3
- Circuit Clinical - SSM Health Cancer Care DePaul ( Site 0166), Bridgeton · a 15 mi di distanza
- Cancer Care Specialists of Illinois ( Site 0152), O'Fallon · a 16 mi di distanza
Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
In reclutamentoFase 2
- Cancer Care Specialists of Central Illinois, Swansea · a 13 mi di distanza
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
In reclutamentoFase 2
- Washington University School of Medicine, St Louis
DALY II USA/ MB-CART2019.1 for DLBCL
In reclutamentoFase 2
- Washington University, St. Louis, St Louis
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
In reclutamentoFase 2
- Washington University School of Medicine, St Louis
- Siteman Cancer Center-South County, St Louis
- Siteman Cancer Center at Christian Hospital, St Louis
- e altri 2
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
In reclutamentoFase 2
- Siteman Cancer Center at Washington University, St Louis
Studi su Linfoma diffuso a grandi cellule B in altre città
- New York City, NY21 studi
- Baldwin Park, CA19 studi
- Chicago, IL18 studi
- Houston, TX17 studi
- Los Angeles, CA17 studi
- Boston, MA16 studi
- Milwaukee, WI16 studi
- Nashville, TN15 studi
- Portland, OR15 studi
- Philadelphia, PA15 studi
- Durham, NC14 studi
- Dallas, TX13 studi
Altri studi a St. Louis
- Cancro del polmone non a piccole cellule73 studi
- Cancro al seno64 studi
- Cancro metastatico54 studi
- Cancro colorettale50 studi
- Cancro alla prostata46 studi
- Cancro (tutti i tipi)46 studi
- Cancro ai polmoni39 studi
- Cancro ovarico38 studi
- Cancro pancreatico33 studi
- Cancro dell'endometrio29 studi
- Carcinoma a cellule squamose della testa e del collo28 studi
- Insufficienza cardiaca26 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.